Verona Pharma has seen its share price skyrocket in anticipation of the commercial launch of its COPD treatment.
Piper Sandler says Trump will usher in a wave of mainstream crypto adoption — so buy these stocks
Piper Sandler sees a handful of stocks outperforming in a friendlier atmosphere for crypto assets under a second Trump administration.
These stocks have major upside because of potential Trump policies, analysts say
Wall Street analysts say there is a slew of stocks set to benefit from a Trump White House.
The 10-year Treasury yield has been rising. Here’s where BlackRock’s Rick Rieder sees an opportunity
You can find solid yield without having to move into lower quality – and without exposing yourself to too much rate sensitivity.
These are the most overbought stocks after Trump’s win this week
Amid a sense of renewed market enthusiasm, shares of some companies that have raced ahead this month could be due for a pullback, by one popular yardstick.
One chart that should make Apple bulls worry and think about trimming
Carter Worth looks at the relative performance of Apple vs. the technology sector.
What Trump tariffs could mean for AI darling Nvidia
Wall Street is questioning how tariffs on semiconductor imports under a Trump administration could impact high-flying AI darling Nvidia.
Goldman Sachs: Why individual investors need to look at private investments to further grow wealth
In the past decade, private investments exploded from $4 trillion to $14 trillion.
This software stock is well-positioned to benefit from Trump’s agenda, trader says
Tony Zhang breaks down a trade in Adobe.
How to profit if rates keep rising, going against the Fed and stock investors
Jeff Kilburg breaks down a trade in the iShares Treasury bond ETF.